Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 16 , ISSUE 2 ( March-April, 2024 ) > List of Articles

Original Article

Histopathological Evaluation of Placentas from COVID-19-positive Mothers: A Study of 100 Placentas

Mangesh M Londhe, Tushar V Patil, Shwetali Akhare

Keywords : Pathology, Placenta, SARS-CoV-2

Citation Information : Londhe MM, Patil TV, Akhare S. Histopathological Evaluation of Placentas from COVID-19-positive Mothers: A Study of 100 Placentas. J South Asian Feder Obs Gynae 2024; 16 (2):93-97.

DOI: 10.5005/jp-journals-10006-2397

License: CC BY-NC 4.0

Published Online: 23-02-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Aims and background: There is a limited availability of data regarding the consequences of COVID-19 disease on placenta and pregnancy outcome. Pregnant females are more vulnerable to COVID-19 infection. In such case scenario, histological study of the placenta gives the best clue of the undergoing disease process, thus helping in management and improvement of pregnancy outcome. Hence, this study was undertaken to evaluate pathological changes in placentas of COVID-19 mothers. Materials and methods: This is a cohort-based, prospective observational study undertaken in tertiary care center. The duration of study is 6 months (July 2020 to December 2020). The placentas of 100 COVID-19 positive mothers were included in this study. Due to the highly infectious nature of the tissue, the placentas were fixed in 10% neutral buffered formalin for 48 hours, followed by grossing, sectioning as per Amsterdam placental workshop group consensus and subjecting it to standard tissue processing protocol. The data were subjected to analysis by MS Excel and SSPS software version 27. Results: The mean age was 27 years. The majority were asymptomatic. On clinical examination, 42% revealed tachycardia, 4% revealed hypertension. The laboratory parameters revealed anemia in 23%, leukocytosis in 5% and raised neutrophil lymphocyte ratio (NLR) in 46. Full-term placentas were observed in 87% with mean weight of 473 grams. The most common finding of maternal malperfusion was increased perivillous fibrin deposition while of fetal malperfusion was chorangiosis. The inflammatory changes were chorioamnionitis and villitis. Conclusions: A causal relationship between maternal COVID-19 infection and its consequences in pregnancy is essential for improving the outcome. Hence, detailed histopathological examination of the placenta is essential. Clinical significance: Due to limited research available on the histopathological changes in the placenta of COVID-19 mothers, its consequences on maternal as well as fetal health need to be established. The detailed knowledge of pathology of the placenta will be helpful in unveiling the causal relationship, thus helping the management of COVID-positive pregnant females.


HTML PDF Share
  1. Menter T, Mertz KD, Jiang S, et al. Placental pathology findings during and after SARS-CoV-2 infection: features of villitis and malperfusion. Pathobiology 2021;88(1):69–77. DOI: 10.1159/000511324.
  2. Shanes ED, Mithal LB, Otero S, et al. Placental Pathology in COVID-19. Am J Clin Pathol 2020;154(1):23–32. DOI: 10.1093/ajcp/aqaa089.
  3. Racicot K, Mor G. Risks associated with viral infections during pregnancy. J Clin Invest 2017 2017;127(5):1591–1599. DOI: 10.1172/JCI87490.
  4. Di Mascio D, Khalil A, Saccone G, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J ObstetGynecol MFM 2020;2(2):100107. DOI: 10.1016/j.ajogmf.2020.100107.
  5. Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med 2020;144(7):799–805. DOI: 10.5858/arpa.2020-0901-SA.
  6. Schwartz DA, Graham AL. Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: Lessons from SARS, MERS, and other human coronavirus infections. Viruses 2020;12(2):194. DOI: 10.3390/v.12020194
  7. Liu D, Li L, Wu X, et al. Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: A preliminary analysis. AJR Am J Roentgenol 2020;215(1):127–132. DOI: 10.2214/AJR.20.23072. Epub 2020 Mar 18. Erratum in: AJR Am J Roentgenol 2020;215(1):262. PMID: 32186894.
  8. Yang H, Sun G, Tang F, et al. Clinical features and outcomes of pregnant women suspected of Coronavirus disease 2019. J Infect 2020;81(1):e40–e44. DOI: 10.1016/j.jinf.2020.04.003.
  9. Yu N, Li W, Kang Q, et al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: A retrospective, single-centre, descriptive study. Lancet Infect Dis 2020;20(5):559–564. DOI: 10.1016/S1473-3099(20)30176-6.
  10. Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies. Acta ObstetGynecol Scand 2020;99(7):823–829. DOI: 10.1111/aogs.13867.
  11. Chen S, Huang B, Luo DJ, et al. Pregnant women with new coronavirus infection: A clinical characteristics and placental pathological analysis of three cases [in Chinese]. Zhonghua Bing Li Xue Za Zhi. 2020;49:E005. DOI: 10.3760/cma.j.cn112151-20200225-00138.
  12. Baud D, Greub G, Favre G, et al. Second-trimester miscarriage in a pregnant woman with SARS-CoV-2 infection. JAMA 2020;323(21): 2198–2200. DOI: 10.1001/jama.2020.7233.
  13. Hosier H, Farhadian S, Morotti R, et al. SARS-CoV-2 infection of the placenta. J Clin Invest 2020;130(9):4947–4953. DOI: 10.1172/JCI139569.
  14. Garg R, Agarwal R, Yadav D, et al. Histopathological changes in placenta of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and maternal and perinatal outcome in COVID-19. J Obstet Gynecol India 2023;73:44–50. DOI: 10.1007/s13224-022-01666-3.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.